More to Offer

PerkinElmer has purchased GE Healthcare’s Tritium (³H) and Carbon-14 (¹⁴C) catalog radiochemicals, Scintillation Proximity Assay (SPA) reagents and Cytostar-T plate assets. PerkinElmer is delighted to announce this enhancement to our radiometric reagents product portfolio. Incorporation of these reagents and technologies will strengthen our industry-leading GPCR and Kinase research product lines, and complement our HTS and Research Reagent solutions. This purchase reinforces PerkinElmer's continued position as the leading company in HTS radiochemicals and related instruments, as we remain committed to supporting critical radiochemicals-based research.